George Dunbar
Director/Board Member at CAPRICOR THERAPEUTICS, INC.
Net worth: 54 363 $ as of 30/04/2024
Network origin in George Dunbar first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 32 | |
Sonus Pharmaceuticals, Inc.
 Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA.
16
| Extinct | Pharmaceuticals: Major | 16 |
| Public Company | Pharmaceuticals: Major | 13 | |
Capricor, Inc.
 Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013.
10
| Subsidiary | Biotechnology | 10 |
Akadeum Life Sciences, Inc.
 Akadeum Life Sciences, Inc. Medical/Nursing ServicesHealth Services Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI.
9
| Holding Company | Medical/Nursing Services | 9 |
Targesome, Inc.
1
| Extinct | Medical/Nursing Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to George Dunbar via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Michigan | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Doctorate Degree Masters Business Admin | |
| The Johns Hopkins University | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree Masters Business Admin | |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Washington Biotechnology & Biomedical Association | Director/Board Member Corporate Officer/Principal Chairman | ||
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Director/Board Member Director of Finance/CFO Director of Finance/CFO | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chairman Founder | |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Chairman Private Equity Investor | |
| University of California, Los Angeles | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
ByHeart, Inc.
 ByHeart, Inc. Miscellaneous Commercial ServicesCommercial Services ByHeart, Inc. engages in the provision of healthcare business. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| Orion Biomedical Fund LP | Chief Investment Officer Corporate Officer/Principal | ||
Virginia Mason Medical Center
 Virginia Mason Medical Center Medical/Nursing ServicesHealth Services Virginia Mason Medical Center provides healthcare services. It offers primary and cancer care, diabetes center, digestive disorders, heart care, neurology and neurosurgery, medicine, surgery, urology, and orthopedics and sports. The company was founded by James Tate Mason, John M. Blackford, and Maurice Dwyer in 1920 and is headquartered in Seattle, WA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Founder Chief Executive Officer | |
Specialty Renal Products, Inc.
 Specialty Renal Products, Inc. Medical SpecialtiesHealth Technology Specialty Renal Products, Inc. develops medical devices for patients with renal diseases. The firm focuses on the development of products for patients with renal disease, including a hemodiafiltration (HDF) system for the treatment of patients with End Stage Renal Disease (ESRD). The company was founded in 2018 and is headquartered in Nashville, TN. | Medical Specialties | Chief Executive Officer Director/Board Member | |
Polynoma LLC
 Polynoma LLC BiotechnologyHealth Technology Part of CK Life Sciences International (Holdings), Inc., Polynoma LLC is an immuno-oncology focused biopharmaceutical company headquartered in San Diego, CA. Polynoma's lead asset is a novel polyvalent antigen vaccine, Seviprotimut-L, for the prevention of recurrence of melanoma. The vaccine has been safely administered in more than 1,000 patients. Polynoma is an immuno-oncology company developing a novel polyvalent antigen therapy for the treatment of melanoma. The company was founded by Paul A. Hopper. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Graduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Founder Founder | |
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Founder Founder | |
| NEPHROS, INC. | Medical Specialties | Chief Executive Officer Chief Executive Officer | |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Breakthrough Properties LLC
 Breakthrough Properties LLC Investment ManagersFinance Breakthrough Properties LLC engages in the provision of real estate development services. It offers best-in-class physical infrastructure, user-driven perspective, and mentorship. The company was founded by Dan Belldegrun and is headquartered in Los Angeles, CA. | Investment Managers | Director/Board Member Chairman | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Founder | |
105 W First Street LLC
 105 W First Street LLC Real Estate Investment TrustsFinance 105 W First Street LLC engages in real estate industry. The company was founded in 2019 and is headquartered in New York, NY. | Real Estate Investment Trusts | Director/Board Member Director/Board Member | |
Virginia Mason Health System
 Virginia Mason Health System Hospital/Nursing ManagementHealth Services Virginia Mason Health System offers medical services. It is the parent company of a group of affiliated organizations including Virginia Mason Medical Center and the Benaroya Research Institute at Virginia Mason. The firm support the healthcare and research missions of the Virginia Mason Medical Center and Benaroya Research Institute at Virginia Mason. The company was founded in 1920 and is headquartered in Seattle, WA. | Hospital/Nursing Management | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
Fluent BioSciences, Inc.
 Fluent BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Fluent BioSciences, Inc. is a privately funded biotechnology company based in Watertown, MA. The company's mission is to revolutionize single-cell biology through accessible, affordable, and scalable solutions for every researcher. Fluent Biosciences aims to accelerate the understanding of biology and disease through its breakthrough pre-templated instant partitions (PipSeq™) technology, which facilitates near-instantaneous self-assembly of individual cells or molecules into millions of uniform partitions without the need for complex instrumentation or expensive consumables. The company was founded in 2018 by Adam Abate, Sepehr Kiani, and Bill Hyun, and Sepehr Kiani has been the CEO since 2018. | Miscellaneous Commercial Services | Founder Founder | |
| University of Illinois | College/University | Graduate Degree Doctorate Degree | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| Michigan State University | College/University | Undergraduate Degree Undergraduate Degree | |
| HEMOSTEMIX INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Breakthrough Services LLC | Director/Board Member Chairman | ||
ATL Ultrasound, Inc.
 ATL Ultrasound, Inc. Medical DistributorsDistribution Services ATL Ultrasound, Inc. manufactures and markets diagnostic medical ultrasound systems. The company is headquartered in Bothell, WA. | Medical Distributors | Corporate Officer/Principal Director of Finance/CFO | |
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Founder | |
Conor Medsystems LLC
 Conor Medsystems LLC Medical SpecialtiesHealth Technology Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA. | Medical Specialties | Director/Board Member Chief Executive Officer | |
D3C1 Allston Co-Investment LP
 D3C1 Allston Co-Investment LP Financial ConglomeratesFinance Part of Breakthrough Properties LLC, D3C1 Allston Co-Investment LP functions as an investment fund. The company is based in Los Angeles, CA. | Financial Conglomerates | Director/Board Member Director/Board Member | |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Biotechnology | Founder Founder | |
Riverbank Capital Securities, Inc.
 Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The company is based in New York, NY. | Investment Banks/Brokers | Director/Board Member Chairman | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Doctorate Degree | |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer |
Statistics
International
| United States | 49 |
| Italy | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 11 |
| Finance | 8 |
| Commercial Services | 5 |
| Health Services | 3 |
Operational
| Director/Board Member | 274 |
| Corporate Officer/Principal | 133 |
| Founder | 59 |
| Undergraduate Degree | 59 |
| President | 58 |
Most connected contacts
| Insiders | |
|---|---|
| Joshua Kazam | 43 |
| Arie Belldegrun | 42 |
| Peter Morgan Kash | 32 |
| Frank Litvack | 29 |
| Earl Collier | 24 |
| Jeffrey L. Cleland | 21 |
| Paul Anthony Mieyal | 18 |
| Michelle Griffin | 18 |
| Alan Fuhrman | 17 |
| Pedro Granadillo | 16 |
| Karimah Es Sabar | 16 |
| Steven Quay | 15 |
| Gregory Sessler | 15 |
| Gerald D. Brennan | 15 |
| Dwight Winstead | 15 |
- Stock Market
- Insiders
- George Dunbar
- Company connections
